- Investing Ideas
- U.S. Pharmaceuticals & Biotech Breakout Stocks
U.S. Pharmaceuticals & Biotech Breakout Stocks
Results
8
Stocks where the price continues to rise after more than a year of consistent gains.
8 companies
EOM Pharmaceuticals Holdings
Market Cap: US$31.4m
A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.
IMUC
US$0.21
7D
39.2%
1Y
108.8%
Delex Healthcare Group
Market Cap: US$6.0m
Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
DELX
US$0.0085
7D
46.6%
1Y
9.8%
International Stem Cell
Market Cap: US$2.2m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.31
7D
74.4%
1Y
107.8%
CBD Life Sciences
Market Cap: US$1.8m
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0003
7D
200.0%
1Y
0%
Myrexis
Market Cap: US$241.4k
Focuses on identifying, evaluating, and making financial investments in life sciences assets.
MYRX
US$0.007
7D
775.0%
1Y
3,400.0%
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%
Pressure BioSciences
Market Cap: US$30.1k
Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.
PBIO
US$0.0007
7D
250.0%
1Y
133.3%
eFFECTOR Therapeutics
Market Cap: US$940.0
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.
EFTR
US$0.0008
7D
33.3%
1Y
300.0%